n the video, Jennifer Brown, MD, PhD, of Dana-Farber Cancer Institute and Richard Furman, MD, noted WM researcher/clinician from Weill Cornell Medical College, discuss the recent approval of ibrutinib therapy for WM patients, along with their perspective on the impact of ibrutinib on WM patients and what the future holds for ibrutinib-based therapy.
The video can be found here(link is external).
OncLive(link is external) provides publications, videos, and other information and resources to oncology professionals to enable them to provide enhanced patient care.